Oral Decitabine/Cedazuridine Is a Tolerable and Effective Ambulatory Regimen for Patients with Advanced Myeloproliferative Neoplasms

被引：0
|
作者：
Sivakumar, Ganesh [1 ]
Handa, Shivani [2 ]
Srisuwananukorn, Andrew [3 ]
Tremblay, Douglas [2 ]
Mascarenhas, John [4 ]
Kremyanskaya, Marina [2 ]
Ginzburg, Yelena [2 ]
Wang, Xiaoli [2 ]
Hoffman, Ronald [4 ]
机构：
[1] Icahn Sch Med Mt Sinai Morningside West, Dept Internal Med, New York, NY USA
[2] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, New York, NY USA
[3] Ohio State Univ, Div Hematol, Dept Internal Med, Comprehens Canc Ctr, Columbus, OH USA
[4] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Dept Med, New York, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-178822
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Patients' perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms
    Zeidan, Amer M.
    Perepezko, Kate
    Salimi, Tehseen
    Washington, Terri
    Epstein, Robert S.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [2] Oral Decitabine/Cedazuridine Is an Effective Ambulatory Therapy for Patients With Myelofibrosis Refractory to JAK2 Inhibitor Therapy
    Handa, Shivani
    Sivakumar, Ganesh
    Srisuwananukorn, Andrew
    Dueck, Amylou
    Tremblay, Douglas
    Mascarenhas, John
    Ginzburg, Yelena
    Kremyanskaya, Marina
    Hoffman, Ronald
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (09): : e314 - e319
  • [3] PATIENTS' PERSPECTIVES ON ORAL DECITABINE AND CEDAZURIDINE FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES
    Zeidan, A.
    Perepezko, K.
    Salimi, T.
    Washington, T.
    Epstein, R.
    LEUKEMIA RESEARCH, 2023, 128
  • [4] Fully oral regimen with decitabine and cedazuridine plus venetoclax: a new step forward for older or unfit patients with acute myeloid leukaemia
    Candoni, Anna
    LANCET HAEMATOLOGY, 2024, 11 (04): : e245 - e246
  • [5] Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms
    Zhou, Selena
    Tremblay, Douglas
    Hoffman, Ronald
    Kremyanskaya, Marina
    Najfeld, Vesna
    Li, Lihua
    Moshier, Erin
    Mascarenhas, John
    ACTA HAEMATOLOGICA, 2021, 144 (01) : 48 - 56
  • [6] PROLONGED SURVIVAL OBSERVED IN 133 MDS PATIENTS TREATED WITH ORAL DECITABINE/CEDAZURIDINE
    Savona, M.
    Mccloskey, J.
    Griffiths, E.
    Yee, K.
    Al-Kali, A.
    Zeidan, A. M.
    Deeg, H. J.
    Patel, P.
    Sabloff, M.
    Keating, M. -M.
    Dao, K. -H.
    Zhu, N.
    Gabrail, N.
    Fazal, S.
    Maly, J.
    Odenike, O.
    Kantarjian, H.
    Dezern, A.
    O'Connell, C.
    Roboz, G.
    Busque, L.
    Wells, R.
    Amin, H.
    Randhawa, J.
    Leber, B.
    Hao, Y.
    Keer, H.
    Azab, M.
    Manero, G. Garcia
    LEUKEMIA RESEARCH, 2021, 108 : S45 - S45
  • [7] Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms
    Ye, Xingnong
    Chen, Dan
    Zheng, Yan
    Zhu, Xiaoqiong
    Fu, Junkai
    Huang, Jian
    ONCOTARGETS AND THERAPY, 2017, 10 : 5425 - 5428
  • [8] Conditioning Regimen of 5-Day Decitabine Administration for Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome and Myeloproliferative Neoplasms
    Cao, Yi-Geng
    He, Yi
    Zhang, Su-Dong
    Liu, Zi-Xian
    Zhai, Wei-Hua
    Ma, Qiao-Ling
    Pang, Ai-Ming
    Wei, Jia-Ling
    Yang, Dong-Ling
    Huang, Yong
    Feng, Si-Zhou
    Jiang, Er-Lie
    Han, Ming-Zhe
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (02) : 285 - 291
  • [9] Administration of direct oral anticoagulants in patients with myeloproliferative neoplasms
    Jean-Christophe Ianotto
    Marie-Anne Couturier
    Hubert Galinat
    Dominique Mottier
    Christian Berthou
    Gaëlle Guillerm
    Eric Lippert
    Aurélien Delluc
    International Journal of Hematology, 2017, 106 : 517 - 521
  • [10] Administration of direct oral anticoagulants in patients with myeloproliferative neoplasms
    Ianotto, Jean-Christophe
    Couturier, Marie-Anne
    Galinat, Hubert
    Mottier, Dominique
    Berthou, Christian
    Guillerm, Gaelle
    Lippert, Eric
    Delluc, Aurelien
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (04) : 517 - 521
12345